The global revenue of Embolization Particle market was valued at 1005.98 M USD in 2016 and is expected to reach USD 2177.07 M USD in 2022. In the future five years, we predict the CAGR of global revenue is 13.73%.
USA has the largest global export quantity and manufacturers in Embolization Particle market, while the Europe is the second sales volume market for Embolization Particle in 2016.
In the industry, Sirtex Medical profits most in 2016 and recent years, while Merit Medical and BTG Medical ranked 2 and 3.The market share of them is 23.11%, 17.44% and 14.53% in 2016.The gap of market share is keep on enlarged due to different strategy.
Nowadays, there are four mainly types of Embolization Particle, including Microspheres, Particles, DEBs and Radio-Embolic Microspheres. And Microspheres is the main type for Embolization Particle, and the Microspheres reached a sales value of approximately 347.54 M USD in 2016, with 34.55% of global sales volume.
Embolization Particle technology is not much mature now, and new enterprises can not surpass existing famous brands on reputation or design in the short term. So, the study group recommends the new entrants need to be considered carefully before enter into this field.
The Global Embolization Particle Sales Market Report 2018 report released by QYResearch provides a basic overview of the Embolization Particle industry, including definition, classification, application and industrial chain structure. Discuss development policies and plans as well as manufacturing processes and cost structures.
The report then focuses on major industry players in Global, including company profiles, product images and specifications, sales, market share, and contact information. More importantly, the Embolization Particle industry development trends and marketing channels were analyzed.Providing the main statistical data on the current status of the industry is a valuable guide and direction for companies and individuals interested in the market.